Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.,Annals of Laboratory Medicine

当前位置： X-MOL 学术 › Ann. Lab. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.
Annals of Laboratory Medicine ( IF 4.0 ) Pub Date : 2022-2-19 , DOI: 10.3343/alm.2022.42.4.406
Mikyoung Park ₁ , Mina Hur ₂ , Hanah Kim ₂ , Chae Hoon Lee ₃ , Jong Ho Lee ₃ , Hyung Woo Kim ₃ , Minjeong Nam ₄

Affiliation

Biomarkers and clinical indices have been investigated for predicting mortality in patients with coronavirus disease (COVID-19). We explored the prognostic utility of procalcitonin (PCT), presepsin, and the Veterans Health Administration COVID-19 (VACO) index for predicting 30-day-mortality in COVID-19 patients.

中文翻译：

降钙素原、Presepsin 和 VACO 指数在预测 COVID-19 住院患者 30 天死亡率方面的预后效用。

生物标志物和临床指标已被研究用于预测冠状病毒病 (COVID-19) 患者的死亡率。我们探讨了降钙素原 (PCT)、presepsin 和退伍军人健康管理局 COVID-19 (VACO) 指数在预测 COVID-19 患者 30 天死亡率方面的预后效用。

更新日期：2022-02-19

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11